openPR Logo
Press release

Colon Cancer Market Perceive Robust Expansion by 2021

01-04-2018 09:53 AM CET | Health & Medicine

Press release from: Persistence Market Research

Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation. The American Society of Clinical Oncology (ASCO) recommends patients affected with colon cancer, for testing of genetic mutation in the KRAS gene which accounts for about 30% to 40% of colon tumors.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/5423

There are three primary recommended therapies for treating colon cancer – surgery, chemotherapy and radiation. Surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy are preferred in early-stage and invasive colon cancer treatment therapy. Besides, chemotherapy involves administration of drugs that destroy cancer cells, usually recommended after the surgery to reduce the risk of recurrence. In addition, targeted drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga) are administered to patients with advanced colon cancer. Radiation therapy utilizes powerful X-ray radiations to kill the cancer cells left after surgery, shrink large tumors before the surgery or relieve symptoms of colon cancer. Usually combined with chemotherapy, radiation therapy aids in reducing the risk of recurrence.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/5423

According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.

Some of the key players contributing to this market include Bedford Laboratories, Sanofi Aventis, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.

Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/5423

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colon Cancer Market Perceive Robust Expansion by 2021 here

News-ID: 884416 • Views: 128

More Releases from Persistence Market Research

Global Waterborne Coatings Market Revenue to Witness Steady Growth Through 2020
Waterborne coatings are green substrates using water as solvent to dissolve a resin, making them environment friendly and easy to apply. These coatings usually contain approximately 80% of water with minimum quantities of other solvents such as glycol ethers. As per the U.S. and European regulations of waterborne coatings to have a VOC content less than 3.5 gallons of water, these are considered eco-friendly in nature. Various types of coatings
Manufacturers to Benefit from Lucrative Growth Prospects in the Global Textile P …
Application of coloring pattern and design to decorate the finished fabric is referred as printing. At the time of printing the color is applied to the fabric so that the color or design is not affected at the time of washing. Textile printing is a process of applying color to fabric in definite pattern and design. Textile printing is sometime confused with dyeing. In dyeing whole fabric is uniformly colored
Demand for Triazole Fungicides to Rise Significantly from Key End-use Industry S …
The growth of the crop can be affected by fungal infection. Fungicides are chemical compound used to kill fungi or fungal spores. Triazole is most widely used fungicides due to their different uses and efficacy against a number of fungal diseases. Triazole is highly effective against many different fungal diseases include rusts, leaf-spotting fungi and powdery mildews. Triazole is used on field crops, fruit trees and vegetables. Repeated use
Global Purified Terephthalic Acid Market Revenue to Witness Rapid Growth in the …
Purified terephthalic acid (PTA) is a chemical which is synthesized from crude oil. It is majorly used to manufacture polyester fiber. Its end-user industries include textile and home furnishing where PTA is required to manufacture garments such as bed sheets, curtains and clothes. Request For Report Sample@https://www.persistencemarketresearch.com/samples/3434 The market for purified terephthalic is expected to witness noticeable expansion in the coming years with the growing demand for polyester, specifically in

All 5 Releases


More Releases for Colon

Colon Cleansing Supplements Market by Key Players - Vita Balance, PRIVATELABELSU …
Global Colon Cleansing Supplements Market: Snapshot Colon cleansing is essential if one needs to lose a few pounds of weight, solve acne problems, or improve their digestive system. There are several supplements are now available that adequately match the requirements and according to the findings of this study, the demand for them would be expanding profitably over the course of 2017 to 2027, gaining traction from increased awareness levels among the
Colon Cancer Market Prevalent Opportunities upto 2021
Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the
Global Therapeutic Landscape Of Colon Cancer Industry Pipeline Review, 2017
Overview Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools
Colon Cancer Therapeutic Pipeline Market Review, H2 2017
Summary Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools
Colon Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 745 pages on Title " Colon Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Colon Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer - Pipeline Review, H1 2017, provides an overview of the Colon Cancer (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon).
Colon Cancer Pipeline Therapeutics Review H1 2017
Colon Cancer Pipeline Drugs Review H1 2017 provides an overview of the Colon Cancer therapeutics (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colon Cancer Pipeline Review H1 2017 Report Inquire @ https://tinyurl.com/Colon-Cancer-Therapeutic . Report Description: Pharmaceutical guide Colon Cancer - Pipeline